Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1950 1
1953 1
1954 3
1955 1
1956 2
1957 1
1958 6
1959 4
1960 4
1961 4
1962 7
1963 12
1964 12
1965 9
1966 9
1967 5
1968 7
1969 15
1970 7
1971 11
1972 22
1973 15
1974 27
1975 23
1976 22
1977 20
1978 18
1979 21
1980 23
1981 25
1982 23
1983 12
1984 19
1985 28
1986 26
1987 19
1988 23
1989 26
1990 25
1991 20
1992 20
1993 22
1994 12
1995 24
1996 22
1997 12
1998 16
1999 12
2000 15
2001 8
2002 16
2003 18
2004 25
2005 24
2006 17
2007 22
2008 35
2009 38
2010 32
2011 48
2012 55
2013 57
2014 40
2015 48
2016 44
2017 47
2018 47
2019 65
2020 43
2021 51
2022 65
2023 63
2024 54
2025 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,614 results

Results by year

Filters applied: . Clear all
Page 1
Modular pooled discovery of synthetic knockin sequences to program durable cell therapies.
Blaeschke F, Chen YY, Apathy R, Daniel B, Chen AY, Chen PA, Sandor K, Zhang W, Li Z, Mowery CT, Yamamoto TN, Nyberg WA, To A, Yu R, Bueno R, Kim MC, Schmidt R, Goodman DB, Feuchtinger T, Eyquem J, Jimmie Ye C, Carnevale J, Satpathy AT, Shifrut E, Roth TL, Marson A. Blaeschke F, et al. Among authors: goodman db. Cell. 2023 Sep 14;186(19):4216-4234.e33. doi: 10.1016/j.cell.2023.08.013. Cell. 2023. PMID: 37714135 Free PMC article.
Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.
Roth TL, Li PJ, Blaeschke F, Nies JF, Apathy R, Mowery C, Yu R, Nguyen MLT, Lee Y, Truong A, Hiatt J, Wu D, Nguyen DN, Goodman D, Bluestone JA, Ye CJ, Roybal K, Shifrut E, Marson A. Roth TL, et al. Among authors: goodman d. Cell. 2020 Apr 30;181(3):728-744.e21. doi: 10.1016/j.cell.2020.03.039. Epub 2020 Apr 16. Cell. 2020. PMID: 32302591 Free PMC article.
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial.
Collins MG, Fahim MA, Pascoe EM, Hawley CM, Johnson DW, Varghese J, Hickey LE, Clayton PA, Dansie KB, McConnochie RC, Vergara LA, Kiriwandeniya C, Reidlinger D, Mount PF, Weinberg L, McArthur CJ, Coates PT, Endre ZH, Goodman D, Howard K, Howell M, Jamboti JS, Kanellis J, Laurence JM, Lim WH, McTaggart SJ, O'Connell PJ, Pilmore HL, Wong G, Chadban SJ; BEST-Fluids Investigators; Australasian Kidney Trials Network. Collins MG, et al. Among authors: goodman d. Lancet. 2023 Jul 8;402(10396):105-117. doi: 10.1016/S0140-6736(23)00642-6. Epub 2023 Jun 18. Lancet. 2023. PMID: 37343576 Clinical Trial.
Plasma retinol-binding protein.
Goodman DS. Goodman DS. Ann N Y Acad Sci. 1980;348:378-90. doi: 10.1111/j.1749-6632.1980.tb21314.x. Ann N Y Acad Sci. 1980. PMID: 6994566 Review.
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci.
Chang CR, Vykunta VS, Lee JHJ, Li K, Kochendoerfer C, Muldoon JJ, Wang CH, Mazumder T, Sun Y, Goodman DB, Nyberg WA, Liu C, Allain V, Rothrock A, Ye CJ, Marson A, Shy BR, Eyquem J. Chang CR, et al. Among authors: goodman db. Nat Biotechnol. 2025 Feb 5:10.1038/s41587-024-02531-6. doi: 10.1038/s41587-024-02531-6. Online ahead of print. Nat Biotechnol. 2025. PMID: 39910194 Free PMC article.
Retinoid-binding proteins.
Goodman DS. Goodman DS. J Am Acad Dermatol. 1982 Apr;6(4 Pt 2 Suppl):583-90. doi: 10.1016/s0190-9622(82)70065-9. J Am Acad Dermatol. 1982. PMID: 6279709 Review.
1,614 results